Prism Pharmaceuticals
Acute care pharmaceutical company engaged in developing and commercializing cardiovascular injectable products.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD93—139m (Dealroom.co estimates Jun 2013.)
Lincoln Nebraska (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | Series A | |
$15.0m | Series B | ||
N/A | - | ||
$338m Valuation: $338m | Acquisition | ||
$15.0m | Series C | ||
Total Funding | AUD46.4m |
Related Content
Recent News about Prism Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.